{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/NE/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T04:48:53.943Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4843,"canonical_name":"Noble Corp plc","cik":"0001895262","uei":null,"lei":null,"duns":null,"ticker":"NE-WTA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":13},"count":13,"timeline":[{"ts":"2026-06-15","kind":"sec.form144","reporter":"Eifler Robert W.","title":"Officer","shares":50000,"usd_value":2275370,"security_title":"Common","approx_sale_date":"2026-06-15","accession_number":"0001959173-26-004671","importance":40.455074022},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Eifler Robert W.","title":"President & CEO","shares":32929,"price_per_share":45.404,"usd_value":1495108,"security_title":"A Ordinary Shares","importance":36.495108316},{"ts":"2026-06-15","kind":"sec.insider.s","reporter":"Eifler Robert W.","title":"President & CEO","shares":17071,"price_per_share":45.708,"usd_value":780281,"security_title":"A Ordinary Shares","importance":35.780281268},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Noble Corp plc — 2026-06-12","url_slug":"/sec/cik-0001895262/8-k/0001895262-26-000134","accession_number":"0001895262-26-000134","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Noble Corp plc — 2026-06-01","url_slug":"/sec/cik-0001895262/8-k/0001895262-26-000129","accession_number":"0001895262-26-000129","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Noble Corp plc — 2026-06-01","url_slug":"/sec/cik-0001895262/8-k/0001895262-26-000131","accession_number":"0001895262-26-000131","importance":35},{"ts":"2026-05-15","kind":"sec.form144","reporter":"Hirshberg Al J.","title":"Director","shares":5000,"usd_value":264700,"security_title":"A ORDINARY SHARES","approx_sale_date":"2026-05-15","accession_number":"0001949846-26-000288","importance":40.05294},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"Hirshberg Al J.","title":null,"shares":3500,"price_per_share":52.625,"usd_value":184188,"security_title":"A Ordinary Shares","importance":35.1841875},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"Hirshberg Al J.","title":null,"shares":1500,"price_per_share":52.6,"usd_value":78900,"security_title":"A Ordinary Shares","importance":35.0789},{"ts":"2026-05-12","kind":"sec.form144","reporter":"GRACE C SLEDGE","title":"Adult Child of Director","shares":724,"usd_value":37364,"security_title":"Common","approx_sale_date":"2026-05-12","accession_number":"0001950047-26-004380","importance":40.007472766},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"SLEDGE CHARLES M","title":null,"shares":724,"price_per_share":51.608,"usd_value":37364,"security_title":"A Ordinary Shares","importance":35.037364192},{"ts":"2026-04-27","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Noble Corp plc — 2026-04-27","url_slug":"/sec/cik-0001895262/10-q/0001895262-26-000111","accession_number":"0001895262-26-000111","importance":45},{"ts":"2026-04-27","kind":"sec.filing","form_type":"8-K","title":"8-K — Noble Corp plc — 2026-04-27","url_slug":"/sec/cik-0001895262/8-k/0001895262-26-000108","accession_number":"0001895262-26-000108","importance":35}]}